These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8575854

  • 21. Inhibition of wound-induced expression of transforming growth factor-beta 1 mRNA by its antisense oligonucleotides.
    Kim HM, Choi DH, Lee YM.
    Pharmacol Res; 1998 Apr; 37(4):289-93. PubMed ID: 9634645
    [Abstract] [Full Text] [Related]

  • 22. [Suppression of the exaggerated growth of vascular smooth muscle cells from SHR by antisense oligodeoxynucleotide to TGF beta].
    Fukuda N.
    Nihon Rinsho; 1993 Jun; 51(6):1663-7. PubMed ID: 8320846
    [Abstract] [Full Text] [Related]

  • 23. Indirect mitogenic effect of transforming growth factor-beta on cell proliferation of subconjunctival fibroblasts.
    Kay EP, Lee HK, Park KS, Lee SC.
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):481-6. PubMed ID: 9501857
    [Abstract] [Full Text] [Related]

  • 24. Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides.
    Arima H, Sakamoto T, Aramaki Y, Ishidate K, Tsuchiya S.
    J Pharm Sci; 1997 Oct; 86(10):1079-84. PubMed ID: 9344161
    [Abstract] [Full Text] [Related]

  • 25. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides.
    Petch AK, Sohail M, Hughes MD, Benter I, Darling J, Southern EM, Akhtar S.
    Biochem Pharmacol; 2003 Sep 01; 66(5):819-30. PubMed ID: 12948863
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms.
    Turley JM, Falk LA, Ruscetti FW, Kasper JJ, Francomano T, Fu T, Bang OS, Birchenall-Roberts MC.
    Cell Growth Differ; 1996 Nov 01; 7(11):1535-44. PubMed ID: 8930403
    [Abstract] [Full Text] [Related]

  • 33. Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation.
    Takabe K, Lebrun JJ, Nagashima Y, Ichikawa Y, Mitsuhashi M, Momiyama N, Ishikawa T, Shimada H, Vale WW.
    Endocrinology; 1999 Jul 01; 140(7):3125-32. PubMed ID: 10385405
    [Abstract] [Full Text] [Related]

  • 34. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL, Coffey RJ, Dugger TC, McCutchen CM, Moses HL, Lyons RM.
    Cell Growth Differ; 1990 Aug 01; 1(8):367-74. PubMed ID: 2177634
    [Abstract] [Full Text] [Related]

  • 35. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
    Ashley DM, Kong FM, Bigner DD, Hale LP.
    Cancer Res; 1998 Jan 15; 58(2):302-9. PubMed ID: 9443409
    [Abstract] [Full Text] [Related]

  • 36. Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
    Grandis JR, Chakraborty A, Zeng Q, Melhem MF, Tweardy DJ.
    J Cell Biochem; 1998 Apr 01; 69(1):55-62. PubMed ID: 9513046
    [Abstract] [Full Text] [Related]

  • 37. A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.
    Coulson JM, Poyner DR, Chantry A, Irwin WJ, Akhtar S.
    Mol Pharmacol; 1996 Aug 01; 50(2):314-25. PubMed ID: 8700139
    [Abstract] [Full Text] [Related]

  • 38. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
    Del Bufalo D, Cucco C, Leonetti C, Citro G, D'Agnano I, Benassi M, Geiser T, Zon G, Calabretta B, Zupi G.
    Br J Cancer; 1996 Aug 01; 74(3):387-93. PubMed ID: 8695353
    [Abstract] [Full Text] [Related]

  • 39. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M.
    Cancer Res; 2004 Nov 01; 64(21):7954-61. PubMed ID: 15520202
    [Abstract] [Full Text] [Related]

  • 40. Control of scarring in adult wounds using antisense transforming growth factor-beta 1 oligodeoxynucleotides.
    Choi BM, Kwak HJ, Jun CD, Park SD, Kim KY, Kim HR, Chung HT.
    Immunol Cell Biol; 1996 Apr 01; 74(2):144-50. PubMed ID: 8724001
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.